大博医疗: 第三届监事会第十四次会议决议公告

Core Points - The company held its 14th meeting of the third supervisory board on March 24, 2025, where all three supervisors attended, ensuring compliance with legal regulations [1] - The supervisory board approved the use of up to 2 billion yuan of temporarily idle self-owned funds for cash management in 2025, aiming to enhance the efficiency of fund utilization and increase cash asset returns without affecting the main business operations [2] - The board also approved a proposal regarding the major shareholder's investment in a subsidiary and joint investment with related parties, confirming that the transaction complies with legal regulations and does not harm the interests of the company or its shareholders [2]